Evidence map›Paper›PMID 36379692›Full record

ArticleGut2023

Letter to the editor:

Jan Bornschein, D Mark Pritchard, Peter Malfertheiner

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Gut, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Jan BornscheinNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-8673-3122
D Mark PritchardDepartment of Cellular and Molecular Physiology, University of Liverpool, Liverpool, UK.
Peter MalfertheinerMedical Department 2, Ludwig-Maximilians-Universitat Munchen, Munchen, Germany peter.malfertheiner@med.ovgu.de.ORCID 0000-0001-8439-9036
Bayer (Germany) · DEUniversity of Liverpool · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DyspepsiaHelicobacter InfectionsHelicobacter pyloriBreath TestsHumansUreaUrea13C-UREA BREATH TESTDYSPEPSIAHELICOBACTER PYLORIHELICOBACTER PYLORI - ASSESSMENT

Identifiers

PMID36379692
OpenAlexW4309167074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.